NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/11/2024
Back to search
Official data from USPTO
CILIAN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
CILIAN
ST13
US500000076323640Class
1, 5, 42
Filing
76323640
Registration
2788015
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
04/11/2024
Classification
Registered
Trademark type
Word
Nice classes
1, 5, 42
Filing date
10/10/2001
Registration date
12/02/2003
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/11/2024
Last transaction
04/11/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
1
Owner type
03
Owner location
Munster, DE
Examiner
CASE, LEIGH CAROLINE
Law office
L50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Cilian AG
Cilian AG
Representatives
Victoria Friedman DENNEMEYER & ASSOCIATES, LLC
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalspeptides and proteins for use in the manufacture of pharmaceuticalsveterinary preparationsadhesives and chemical intermediates; peptides and proteins for use in the science industryfor medical researchexcluding multiple sclerosisfor medical diagnostic purposesexcluding multiple sclerosis
Class 5
Pharmaceutical preparations comprising peptides or proteins for the treatment of vascularinflammatoryneoplasmdegenerativeinfectiouscongenitalautoimmunetraumatic and endocrine diseases and disordersexcluding multiple sclerosis
Class 42
Scientific and industrial research in the field of the expression and application of peptides and proteins
Publications
History of USPTO decisions and trademark events.
43 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
04/11/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/11/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/10/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
11/29/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/02/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/02/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/02/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/02/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/02/2022
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/02/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/22/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/22/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/22/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/22/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/22/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/22/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/22/2021
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/08/2014
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/08/2014
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/08/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/08/2014
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
02/20/2014
E89R
TEAS SECTION 8 & 9 RECEIVED
02/20/2014
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
12/02/2009
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/01/2009
8.AF
REGISTERED - SEC. 8 (6-YR) FILED
11/30/2009
ES8R
TEAS SECTION 8 RECEIVED
11/30/2009
CFIT
CASE FILE IN TICRS
05/27/2008
CORV
REVIEW OF CORRESPONDENCE COMPLETE
09/09/2006
PAPER RECEIVED
08/21/2006
R.PR
REGISTERED-PRINCIPAL REGISTER
12/02/2003
PUBO
PUBLISHED FOR OPPOSITION
09/09/2003
NPUB
NOTICE OF PUBLICATION
08/20/2003
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/09/2003
1.BD
Sec. 1(B) CLAIM DELETED
04/25/2003
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/25/2003
PAPER RECEIVED
04/25/2003
DOCK
ASSIGNED TO EXAMINER
10/15/2002
CNSL
LETTER OF SUSPENSION MAILED
07/15/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/17/2002
CNRT
NON-FINAL ACTION MAILED
12/17/2001
DOCK
ASSIGNED TO EXAMINER
12/13/2001
Continuous trademark protection
Get notified about every new filing that threatens CILIAN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.